As another strategy for the treatment of AD, the neuroprotective effect of rosmarinic acid through various mechanisms such as cholinesterase inhibitory activity, anti-amyloidogenic effect, etc., has been reported by multiple researchers, including our group [29,30,31,32]. Here, BCHE is linked to Alzheimer disease.